On October 22, Nobel Prize–winning biochemist Dr. Jennifer Doudna dined with supporters of UCSB Arts & Lectures (A&L) and the Cancer Foundation of S.B. (CFSB). The intimate, al fresco dinner party at ...

Nobel Prize winner Jennifer Doudna, who co-invented CRISPR-Cas9 genome editing technology, joined President Christina Paxson P’19 for a virtual conversation on CRISPR’s wide-ranging applications and ...

When Martin Kampmann, PhD, set out to explore the workings of the human brain, he was captivated by its greatest mystery: how a network of cells could produce something as intangible as thoughts, ...

Nobel Prize–winning biochemist Dr. Jennifer Doudna is cracking the code of nature to address big issues, using the tiniest parts of us. On Tuesday, UCSB Arts & Lectures and the Cancer Foundation of ...

In a groundbreaking fusion of artificial intelligence and gene editing, researchers are leveraging machine learning to enhance CRISPR technology’s precision and efficiency. This integration is opening ...

Although existing CRISPR-Cas-based imaging methods can target endogenous genomic sequences, their applications are limited by system complexity and sensitivity, particularly when imaging ...

You've probably heard about the gene-editing technology CRISPR. The massive biotech breakthrough, which has emerged in the last decade, has mainly been touted for the ways it will let scientists edit ...

SAN DIEGO & BRISBANE, Calif.--(BUSINESS WIRE)--VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive license agreement with Mammoth Biosciences, ...